These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21220773)

  • 1. Reduced naive CD4 T cell numbers and impaired induction of CD27 in response to T cell receptor stimulation reflect a state of immune activation in chronic hepatitis C virus infection.
    Yonkers NL; Sieg S; Rodriguez B; Anthony DD
    J Infect Dis; 2011 Mar; 203(5):635-45. PubMed ID: 21220773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naïve CD4+ T Cell Lymphopenia and Apoptosis in Chronic Hepatitis C Virus Infection Is Driven by the CD31+ Subset and Is Partially Normalized in Direct-Acting Antiviral Treated Persons.
    Auma AWN; Shive CL; Lange A; Damjanovska S; Kowal C; Zebrowski E; Pandiyan P; Wilson B; Kalayjian RC; Canaday DH; Anthony DD
    Front Immunol; 2021; 12():641230. PubMed ID: 33912168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy?
    Lee S; Hammond T; Watson MW; Flexman JP; Cheng W; Fernandez S; Price P
    Clin Exp Immunol; 2010 Jul; 161(1):118-26. PubMed ID: 20408862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
    Wedemeyer H; He XS; Nascimbeni M; Davis AR; Greenberg HB; Hoofnagle JH; Liang TJ; Alter H; Rehermann B
    J Immunol; 2002 Sep; 169(6):3447-58. PubMed ID: 12218168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
    Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
    Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+CXCR5+ T cells activate CD27+IgG+ B cells via IL-21 in patients with hepatitis C virus infection.
    Kong FY; Feng B; Zhang HH; Rao HY; Wang JH; Cong X; Wei L
    Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):55-64. PubMed ID: 26818544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group.
    Cacoub P; Musset L; Hausfater P; Ghillani P; Fabiani FL; Charlotte F; Angevin E; Opolon P; Poynard T; Piette JC; Autran B
    Clin Exp Immunol; 1998 Jul; 113(1):48-54. PubMed ID: 9697982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hepatitis C virus coinfection on CD4⁺ T cells of HIV-infected patients receiving HAART.
    Shmagel KV; Saidakova EV; Korolevskaya LB; Shmagel NG; Chereshnev VA; Anthony DD; Lederman MM
    AIDS; 2014 Oct; 28(16):2381-8. PubMed ID: 25111083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection.
    Cummings KL; Rosen HR; Hahn YS
    Clin Immunol; 2009 Sep; 132(3):401-11. PubMed ID: 19473882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
    Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
    J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
    Semmo N; Krashias G; Willberg C; Klenerman P
    J Viral Hepat; 2007 Jul; 14(7):492-502. PubMed ID: 17576391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naive and Memory CD4⁺ T Cells Are Differentially Affected in Indonesian HIV Patients Responding to ART.
    Tanaskovic S; Fernandez S; Saraswati H; Yunihastuti E; Gani RA; Djauzi S; Price P
    Viral Immunol; 2016 Apr; 29(3):176-83. PubMed ID: 27035638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels.
    Bolacchi F; Sinistro A; Ciaprini C; Demin F; Capozzi M; Carducci FC; Drapeau CM; Rocchi G; Bergamini A
    Clin Exp Immunol; 2006 May; 144(2):188-96. PubMed ID: 16634790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distributional characteristics of CD25 and CD127 on CD4+ T cell subsets in chronic HCV infection.
    Shen T; Chen X; Xu Q; Lu F; Liu S
    Arch Virol; 2010 May; 155(5):627-34. PubMed ID: 20204427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
    Najafi Fard S; Schietroma I; Corano Scheri G; Giustini N; Serafino S; Cavallari EN; Pinacchio C; De Girolamo G; Ceccarelli G; Scagnolari C; Vullo V; d'Ettorre G
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):319-329. PubMed ID: 29279268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired induction of CD27 and CD28 predicts naive CD4 T cell proliferation defects in HIV disease.
    Luciano AA; Lederman MM; Valentin-Torres A; Bazdar DA; Sieg SF
    J Immunol; 2007 Sep; 179(6):3543-9. PubMed ID: 17785788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.
    Boettler T; Spangenberg HC; Neumann-Haefelin C; Panther E; Urbani S; Ferrari C; Blum HE; von Weizsäcker F; Thimme R
    J Virol; 2005 Jun; 79(12):7860-7. PubMed ID: 15919940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses.
    Moorman JP; Zhang CL; Ni L; Ma CJ; Zhang Y; Wu XY; Thayer P; Islam TM; Borthwick T; Yao ZQ
    Vaccine; 2011 Apr; 29(17):3169-76. PubMed ID: 21376795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-alfa-2a and ribavirin.
    Neau D; Galpérine T; Legrand E; Pitard V; Neau-Cransac M; Moreau JF; Ragnaud JM; Dupon M; Fleury H; Lafon ME
    HIV Med; 2003 Apr; 4(2):120-6. PubMed ID: 12702132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women.
    Kuniholm MH; Xie X; Anastos K; Kaplan RC; Xue X; Kovacs A; Peters MG; Seaberg EC; French AL; Young MA; Augenbraun M; Martinson JA; Bush KA; Landay AL; Strickler HD
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):295-303. PubMed ID: 25314250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.